Clinical trial
Effect of Cabergoline on Subendometrial Vascularity During ICSI Cycles and Pregnancy Outcome
NCT02306564 is registered in ClinicalTrials.gov with Kasr El Aini Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Effect of Cabergoline on Subendometrial Vascularity During ICSI Cycles and Pregnancy Outcome
- Lead sponsor
- Kasr El Aini Hospital
- Phase
- Phase 2/3
- Overall status
- Unknown status
- Start date
- December 31, 2014
- Completion date
- December 31, 2017
- Enrollment
- 150 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.